Enrollment Milestone Achieved in MyPEAK™-1 and RIDGE™-1 Clinical Trials
August 6, 2025 - 23:19
Tenaya Therapeutics has announced significant progress in its clinical trials, marking a pivotal moment for its innovative therapies targeting specific heart conditions. The enrollment process for Cohorts 1 and 2 of the MyPEAK™-1 Phase 1b/2 trial of TN-201, aimed at treating MYBPC3-associated hypertrophic cardiomyopathy (HCM), has been successfully completed. This achievement has been bolstered by a positive safety review from the Data Safety Monitoring Board (DSMB), which has now allowed the company to proceed with the enrollment of expansion cohorts.
In addition, the RIDGE™-1 Phase 1b trial of TN-401 has also made strides, with Cohort 1 fully enrolled and the first patient with PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC) dosed in Cohort 2. This advancement follows the DSMB's recommendation to escalate dosing and expand the trial.
Tenaya Therapeutics is set to provide data readouts from both clinical programs in the fourth quarter of 2025, with a cash runway projected to extend into the second half of 2026, ensuring continued development of these promising therapies.
MORE NEWS
August 19, 2025 - 04:30
Explore TPG RE Finance Trust's Impressive 10.5% Dividend YieldTPG RE Finance Trust has garnered attention for its remarkable 10.5% dividend yield, a figure that stands out in the current financial landscape. This yield is supported by the company`s solid...
August 18, 2025 - 04:14
Are Financial Conditions Returning to Post-COVID Lows?Financial conditions have reached some of the most favorable levels seen since the pandemic`s onset, sparking discussions about the implications for the economy. As central banks, particularly the...
August 17, 2025 - 04:20
Insights on Short Selling Trends in S&P 500 Financial Stocks for JuneIn June, short selling activity against S&P 500 financial stocks surged significantly, reflecting heightened investor skepticism about the sector`s performance. This rise in short interest...
August 16, 2025 - 04:03
Mixed Market Performance: Dow Jones Climbs While S&P 500 and Nasdaq DeclineIn a fluctuating trading session on Friday, the stock market exhibited a mixed performance, with the Dow Jones Industrial Average managing to gain ground while the S&P 500 and Nasdaq Composite...